Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-680
Closed -$369K 1214
2024
Q2
$369K Buy
+680
New +$389K 0.01% 856
2021
Q4
Sell
-434
Closed -$202K 1911
2021
Q3
$202K Sell
434
-1,080
-71% -$509K ﹤0.01% 852
2021
Q2
$718K Buy
1,514
+87
+6% +$41.8K 0.01% 803
2021
Q1
$656K Buy
1,427
+457
+47% +$224K 0.01% 937
2020
Q4
$517K Sell
970
-1,978
-67% -$972K 0.01% 896
2020
Q3
$1.42M Buy
2,948
+1,876
+175% +$920K 0.04% 534
2020
Q2
$484K Buy
+1,072
New +$479K 0.01% 1237
2020
Q1
Sell
-1,824
Closed -$801K 1348
2019
Q4
$801K Sell
1,824
-1,273
-41% -$536K 0.01% 1095
2019
Q3
$1.29M Buy
+3,097
New +$1.26M 0.03% 613
2019
Q2
Sell
-2,114
Closed -$676K 1766
2019
Q1
$676K Buy
2,114
+1,350
+177% +$415K 0.02% 924
2018
Q4
$216K Sell
764
-1,106
-59% -$334K 0.01% 1017
2018
Q3
$598K Sell
1,870
-46,640
-96% -$14.9M 0.01% 954
2018
Q2
$15.6M Buy
48,510
+47,644
+5,502% +$14.9M 0.29% 49
2018
Q1
$236K Sell
866
-4,221
-83% -$1.12M ﹤0.01% 1733
2017
Q4
$1.24M Buy
5,087
+3,174
+166% +$721K 0.02% 922
2017
Q3
$387K Sell
1,913
-887
-32% -$174K 0.01% 1664
2017
Q2
$573K Buy
+2,800
New +$558K 0.01% 1468
2016
Q3
Sell
-4,324
Closed -$590K 1862
2016
Q2
$590K Sell
4,324
-1,895
-30% -$251K 0.01% 1457
2016
Q1
$841K Buy
+6,219
New +$841K 0.01% 987
2015
Q4
Sell
-1,678
Closed -$223K 1723
2015
Q3
$223K Sell
1,678
-2,286
-58% -$320K 0.01% 1421
2015
Q2
$520K Buy
+3,964
New +$490K 0.01% 1062
2015
Q1
Sell
-3,569
Closed -$377K 1214
2014
Q4
$377K Buy
+3,569
New +$377K 0.02% 774
2014
Q3
Sell
-2,165
Closed -$203K 1038
2014
Q2
$203K Buy
+2,165
New +$192K 0.01% 967
2014
Q1
Sell
-21,002
Closed -$1.61M 719
2013
Q4
$1.61M Buy
+21,002
New +$1.55M 0.08% 250

Other funds holding CHE

Paloma Partners's CHE Position: Q3 2024 in Review

Paloma Partners sold out of Chemed (CHE) in Q3 2024, closing a stake of 680 shares — an estimated $369K sold.

Paloma Partners first reported a position in CHE in Q4 2013 and held it in 24 quarters. The position peaked at $15.6M in Q2 2018. 528 funds tracked by Wall St. Rank hold CHE as of Q3 2024.

  • Paloma Partners reported no remaining Chemed position as of Q3 2024 after selling out during the quarter.
  • Paloma Partners sold 680 Chemed shares in Q3 2024, an estimated $369K.
  • Paloma Partners first reported a position in Chemed in Q4 2013 and held it in 24 quarters.
  • Paloma Partners's Chemed position peaked at $15.6M in Q2 2018.
  • 528 funds tracked by Wall St. Rank held Chemed as of Q3 2024.

Based on Paloma Partners's 13F filing for Q3 2024, filed 14 Nov 2024.